- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03669341
Assessment of 2 Different Techniques for Suppression of Respiratory Motion in Lung Cancer Treatment With Proton Therapy Using Magnetic Resonance Imaging (MRI)
June 4, 2021 updated by: Paul Scherrer Institut, Center for Proton Therapy
Short-term Apnoea Training With Deep Inspiration Breath Hold vs High Frequency Percussive Ventilation for Apnoea-like Suppression of Respiratory Motion: a Pilot Study Using Magnetic Resonance Imaging at 1.5T Assessing Their Application for Proton Therapy Treatment of Lung Tumors
Since 1996 proton therapy has been applied very successfully at the Paul Scherrer Institute in Switzerland to irradiate deep-seated, stationary tumors.
In order to treat tumors within an organ which moves due to breathing (e.g.
lung) motion mitigation strategies need to be implemented to ensure the precise irradiation of the moving target.
The aim of this study is to assess the feasibility and compare (via MRI imaging) 2 techniques which "freeze" the movement of the lung by breath hold.
One method is suppression of respiratory movement via high-frequency, mechanical ventilation by means of a Jet Ventilator (HFPV).
The other technique is deep Inspiration breath-hold (DIBH) with Hyperventilation and simultaneous Inspiration of 100% O2 including daily breath-hold exercise.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Aargau
-
Villigen, Aargau, Switzerland, 5232
- Paul Scherrer Institut, Center for Proton Therapy
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- ability to give informed consent by signature
- healthy, i.e. normal physical and mental status
Exclusion Criteria:
- contraindications to MRI (non-MRI-suitable electronical & metal implants, claustrophobia)
- women who are pregnant or are breast feeding
- acute or chronic illness
- known or suspected non-compliance, drug or alcohol abuse
- inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
- presence of any psychological or sociological condition potentially hampering compliance with the study protocol
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Deep Inspiration Breath Hold (DIBH)
DIBH extended by prior hyperventilation while breathing 100% O2
|
human-based DIBH method with short-term breath-hold training
|
|
Active Comparator: High Frequency Percussive Ventilation (HFPV)
passive Ventilation by a jet ventilator
|
device-based HFPV technique
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in MRI Images
Time Frame: 3 weeks
|
pulmonary anatomical structure points are evaluated by means of MRI scans.
The difference of these MRI evaluations between the DIBH- and HFPV-technique is the primary outcome measure.
|
3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in breath-hold duration
Time Frame: 3 weeks
|
The difference between the DIBH- and HFPV-technique in breath-hold Duration is the secondary outcome measure
|
3 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Frank Emert, PhD, Paul Scherrer Institut, Center for Proton Therapy
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 10, 2018
Primary Completion (Actual)
March 11, 2019
Study Completion (Actual)
August 14, 2019
Study Registration Dates
First Submitted
September 11, 2018
First Submitted That Met QC Criteria
September 12, 2018
First Posted (Actual)
September 13, 2018
Study Record Updates
Last Update Posted (Actual)
June 9, 2021
Last Update Submitted That Met QC Criteria
June 4, 2021
Last Verified
June 1, 2021
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- APNOPART_2018
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Danone NutriciaCompletedHealthy Elderly | Healthy VolunteersChina
-
National and Kapodistrian University of AthensCompletedHealthy Adults | Healthy Volunteers OnlyGreece
Clinical Trials on Deep Inspiration Breath Hold (DIBH)
-
Fondazione IRCCS Policlinico San Matteo di PaviaRecruitingBreast Cancer | RadiotherapyItaly
-
Peking Union Medical College HospitalRecruitingBreast Cancer | Optical Surface Monitoring Technology | Large-segment RadiotherapyChina
-
Shu lian WangRecruitingBreast Cancer | Cardiac EventChina
-
Nishat TasnimBangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshActive, not recruitingRadiotherapy, Adjuvant | Carcinoma Breast | Radiation Tolerance | Radiation Induced Cardiac Damage | Radiotherapy; Adverse Effect | Radiation Therapy for Primary Breast Cancer | Radiation Induced Lung Injury (RILI)Bangladesh
-
Medical College of WisconsinCompletedThe Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation ExposureBreast Cancer | Invasive Breast Cancer | Ductal Carcinoma in SituUnited States
-
AHS Cancer Control AlbertaCross Cancer InstituteCompleted
-
Case Comprehensive Cancer CenterVarian Medical SystemsCompletedA Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary DoseLung Cancer | Left Sided Breast CancerUnited States
-
Royal Marsden NHS Foundation TrustCompleted
-
Istanbul Gelisim UniversityNot yet recruitingCognitive Performance | Sport PhysiologyTurkey (Türkiye)
-
Rigshospitalet, DenmarkHelsinki University Central Hospital; Aarhus University Hospital; Tampere University...RecruitingPediatric CancerDenmark, Finland